Literature DB >> 10959808

Connective tissue growth factor in human liver cirrhosis.

M Abou-Shady1, H Friess, A Zimmermann, F F di Mola, X Z Guo, H U Baer, M W Büchler.   

Abstract

BACKGROUND: Connective tissue growth factor (CTGF) belongs to a family of factors that regulate fibrogenesis and wound healing. While the significance of transforming growth factor beta (TGF-beta) in liver fibrosis is well established, the role of CTGF in fibrosing hepatopathy is still unknown.
METHODS: CTGF was analyzed in 10 normal and in 16 cirrhotic liver tissue samples. Northern blot analysis was used to examine the concomitant expression of CTGF and TGF-beta1 mRNAs, and the cellular localization of CTGF mRNA was studied by in situ hybridization. For identification of myofibroblasts and activated hepatic stellate cells, alpha-smooth muscle actin (alpha-SMA) immunohistochemistry was used.
RESULTS: Northern blot analysis showed 6.5-fold enhanced expression of CTGF mRNA and 7.8-fold enhanced expression of TGF-beta1 mRNA in liver cirrhosis in comparison with normal controls (p<0.01). By in situ hybridization, CTGF mRNA was detectable in only a few spindle cells in the portal tracts in normal liver samples. In contrast, there was strong expression of CTGF mRNA in fibroblasts and myofibroblast-like cells present in fibrous septa surrounding the cirrhotic nodules, in stellate cells, in endothelial cells and in mesenchymal cells around ductular proliferations, and in ductular epithelial cells. There was a strong correlation between CTGF mRNA and TGF-beta1 mRNA as well as the degree of fibrosis (p<0.01).
CONCLUSIONS: Overexpression of CTGF in liver cirrhosis, especially in fibroblasts/myofibroblasts and stellate cells, suggests that this novel factor may play an important role in hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959808     DOI: 10.1034/j.1600-0676.2000.020004296.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  27 in total

1.  Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.

Authors:  N E El-Bassiouni; M M F Nosseir; M E Madkour; M M K Zoheiry; I W Bekheit; R A Ibrahim; I M Ibrahim; A E El Bassiouny
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

2.  Transforming growth factor-β (TGF-β) expression is increased in the subsynovial connective tissues of patients with idiopathic carpal tunnel syndrome.

Authors:  Takako Chikenji; Anne Gingery; Chunfeng Zhao; Sandra M Passe; Yasuhiro Ozasa; Dirk Larson; Kai-Nan An; Peter C Amadio
Journal:  J Orthop Res       Date:  2013-09-09       Impact factor: 3.494

3.  Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Authors:  Vijay Subramanian; Anil B Seetharam; Neeta Vachharajani; Venkataswarup Tiriveedhi; Nataraju Angaswamy; Sabarinathan Ramachandran; Jeffrey S Crippin; Surendra Shenoy; William C Chapman; Thalachallour Mohanakumar; Christopher D Anderson
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

4.  Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.

Authors:  Li Chen; Alyssa Charrier; Yu Zhou; Ruju Chen; Bo Yu; Kitty Agarwal; Hidekazu Tsukamoto; L James Lee; Michael E Paulaitis; David R Brigstock
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

5.  The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.

Authors:  Peter J Lewindon; Tamara N Pereira; Anita C Hoskins; Kim R Bridle; Richard M Williamson; Ross W Shepherd; Grant A Ramm
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

6.  Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice.

Authors:  Takahiro Kodama; Tetsuo Takehara; Hayato Hikita; Satoshi Shimizu; Minoru Shigekawa; Hinako Tsunematsu; Wei Li; Takuya Miyagi; Atsushi Hosui; Tomohide Tatsumi; Hisashi Ishida; Tatsuya Kanto; Naoki Hiramatsu; Satoshi Kubota; Masaharu Takigawa; Yoshito Tomimaru; Akira Tomokuni; Hiroaki Nagano; Yuichiro Doki; Masaki Mori; Norio Hayashi
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

7.  Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.

Authors:  Yan Liu; Heng Liu; Christoph Meyer; Jun Li; Silvio Nadalin; Alfred Königsrainer; Honglei Weng; Steven Dooley; Peter ten Dijke
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

8.  The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis.

Authors:  Dai Zhang; Nian-Yue Wang; Cheng-Bao Yang; Guo-Xiang Fang; Wei Liu; Jian Wen; Chan Luo
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

9.  Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: an immunohistochemical and molecular analysis.

Authors:  Irene Esposito; Frank Bergmann; Roland Penzel; Fabio F di Mola; Shailesh Shrikhande; Markus W Büchler; Helmut Friess; Herwart F Otto
Journal:  Virchows Arch       Date:  2004-01-14       Impact factor: 4.064

10.  Connective tissue growth factor and progressive fibrosis in biliary atresia.

Authors:  Hiroyuki Kobayashi; Nobukazu Hayashi; Kenji Hayashi; Atsuyuki Yamataka; Geoffrey J Lane; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.